Subscribe for $1
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Pharmaceutical Industry

Pharmaceutical Industry

Page 100 of 100

Abbvie looks like dropping Shire bid after crackdown on tax inversions
International

Abbvie looks like dropping Shire bid after crackdown on tax inversions

By Geoffrey Smith
October 15, 2014
Valeant Offers to Buy Allergan With Pershing's Support
Finance

Valeant seen raising offer for Allergan to clinch deal

By Geoffrey Smith
October 8, 2014
Berlin Hospital Prepares For Possible Ebola Cases
International

Dallas Ebola patient gets experimental drug

By TIME
October 7, 2014
Ebola outbreak’s impact on 5 key industries
International

Ebola outbreak’s impact on 5 key industries

By Benjamin Snyder
October 3, 2014
511882721
International

Salix scraps inversion-based deal to buy Cosmo

By Reuters
October 3, 2014
International
Finance

As Ebola spreads, drug companies race to develop treatments

By Laura Lorenzetti
October 2, 2014
Berlin Hospital Prepares For Possible Ebola Cases
Finance

Stocks roiled by news of first American Ebola case

By Laura Lorenzetti
October 1, 2014
Johnson & Johnson Products Ahead Of Earnings
Finance

J&J buys Alios BioPharma to gain access to infant medicine

By Laura Lorenzetti
September 30, 2014
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

Tax inversion target companies hit by U.S. crackdown

By Laura Lorenzetti
September 23, 2014
Merck pays $17 billion for chemical-maker Sigma-Aldrich
Finance

Merck pays $17 billion for chemical-maker Sigma-Aldrich

By Laura Lorenzetti
September 22, 2014
A Walgreen Co. store in Oak Park, Ill.
Finance

Government benefits, not political pressure, convinced Walgreen to stay stateside

By Laura Lorenzetti
September 16, 2014
Tuesday, October 15, 2013Fortune The Most Powerful WomenWashington, D.C., USA9:00 AM SOLUTIONS DESK OPENSPhotograph by Stuart Isett/Fortune Most Powerful Women

Highest-paid female executive seeks immortality—digitally

By Robert Hackett
September 12, 2014
How to stop Ebola
Features

How to stop Ebola

By Erika Fry
September 4, 2014
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
Retail

CVS stakes its claim in the healthcare market with new name change

By Laura Lorenzetti
September 3, 2014
Roche FY Earnings Press Conference
Finance

Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug

By Laura Lorenzetti
August 25, 2014

Most Popular

  • Innovation
    An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants...
    By Marco Quiroz-Gutierrez
  • Success
    Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that...
    By Sydney Lake
  • Commentary
    'The Pitt': a masterclass display of DEI in action 
    By Robert Raben
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.